6 January 2025
\n \n \n \nThe Royal Society of Biology have recognised Associate Professor Benjamin Schuster-B\u00f6ckler from NDM's Ludwig Institute for Cancer Research as a Fellow in their January 2025 nominations round.
\n \n\n \n \n3 January 2025
\n \n \n \nA new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
\n \n\n \n \n19 December 2024
\n \n \n \nMahidol Oxford Tropical Medicine Research Unit (MORU) have led the world\u2019s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.
\n \n\n \n \n18 December 2024
\n \n \n \nA study aimed at increasing understanding of how cells function has received funding of \u00a36.4 million. Led by the University of Strathclyde, NDM\u2019s Division of Structural Biology (STRUBI) and collaborators from other universities across the UK will be working together to increase understanding in this area of research.
\n \n\n \n \n17 December 2024
\n \n \n \nNDM\u2019s Dr Lennard Lee has been featured in Fujifilm Europe\u2019s 90th Anniversary celebration documentary series, which honours 20 exceptional innovators helping to shape the future across Europe. Dr Lee has been recognised as a UK exemplar for his groundbreaking contributions to the cancer vaccines research field, accelerating the uptake of digital trials, and demonstrating a faster, simpler, and more efficient model for clinical trials.
\n \n\n \n \n16 December 2024
\n \n \n \nA new study led by Professor Ignacio Melero of NDM's Centre for Immuno-oncology and the University of Navarra and has highlighted a way to combat resistance to cancer immunotherapy in solid tumours by using antibodies that target GDF-15 protein.
\n \n\n \n \n13 December 2024
\n \n \n \nA team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa.
\n \n\n \n \n12 December 2024
\n \n \n \nProfessor Anneke Lucassen will chair the Public and Community Engagement with Research Advisory Board and launch the 2024-2029 strategy as the new Academic Champion for Oxford University.
\n \n\n \n \n11 December 2024
\n \n \n \nThe Medical Research Council (MRC), part of UKRI, is launching its first two Centres of Research Excellence (CoRE), which will develop transformative new advanced therapeutics for currently untreatable diseases. Oxford is leading one of these Centres and co-leading the other. Together, these international collaborations will receive up to \u00a350 million each over 14 years.
\n \n\n \n \n10 December 2024
\n \n \n \nPSI researcher Md Zakiul Hassan, the inaugural Oxford-MoH Foundation DPhil Scholar, has been recognised as 2024 ISID Emerging Leader in International Infectious Diseases. The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.
\n \n\n \n \n4 December 2024
\n \n \n \nDr Xin Hui Chan has won the competitive 2024 Barnett Christie Lecture award of the British Infection Association. As part of the award, Dr Chan delivered a lecture entitled \u2018Drugs for Tropical Infections: Challenges, Opportunities, and the Infectious Disease Physician\u2019.
\n \n\n \n \n3 December 2024
\n \n \n \nResearchers at NDM\u2019s Ludwig Cancer Research, the \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne and other Oxford departments report the use of surfactant-supported assembly of freestanding microscale hydrogel droplets to construct iontronic modules and biointerfaces.
\n \n\n \n \n2 December 2024
\n \n \n \nAn injection given during some asthma and chronic obstructive pulmonary disease (COPD) attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30 percent.
\n \n\n \n \n29 November 2024
\n \n \n \nThe Kenya Medical Research Institute (KEMRI) has signed a seven-year memorandum of agreement with the Wellcome Trust and the University of Oxford. Under this collaboration, Wellcome has awarded \u00a391 million (KES 15 billion) to support research over the next seven years. KEMRI have been collaborating with the Wellcome Trust and the University of Oxford on improving health through research for over 35 years.
\n \n\n \n \n28 November 2024
\n \n \n \nA new study by NDM researchers and collaborators has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.
\n \n\n \n \n27 November 2024
\n \n \n \nOUCRU researchers from Indonesia, Nepal, and Vietnam contributed to the newly published WHO research priorities for antimicrobial resistance. These top 40 priorities, developed by the World Health Organization (WHO) with global collaborators, aim to guide research into drug-resistant infections over the next five years, with a special focus on challenges faced by low- and middle-income countries (LMICs).
\n \n\n \n \n26 November 2024
\n \n \n \nResearchers at Ludwig Cancer Research have leveraged functional genomics to suppress the function of the mutant histones responsible for driving 80% of incurable childhood brain tumours.
\n \n\n \n \n25 November 2024
\n \n \n \nNicky Whiffin, Associate Professor and Sir Henry Dale Fellow at the University of Oxford\u2019s Big Data Institute and Centre for Human Genetics, has been awarded the 2025 Balfour Lecture by the Genetics Society.
\n \n\n \n \n24 November 2024
\n \n \n \nAntimicrobial resistance (AMR) is a growing global health emergency that threatens to reverse decades of medical progress. In Vietnam, the issue is particularly acute in underserved regions, where healthcare resources are often limited and diagnostic tools are scarce. NDM's Oxford University Clinical Research Unit (OUCRU) and the Phu Tho Department of Health have partnered to improve antibiotic stewardship and microbiology capabilities in underserved districts of the province.
\n \n\n \n \n22 November 2024
\n \n \n \nThe National Institute for Health and Care Research (NIHR) has awarded the Modernising Medical Microbiology consortium \u00a311 million to address major public health threat, antimicrobial resistance. The Oxford Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, hosted by the Nuffield Department of Medicine since 2014, is one of 13 HPRUs funded by NIHR as part of an \u00a380 million funding boost.
\n \n\n \n \n